Ad
related to: regn stock highest price
Search results
Results from the WOW.Com Content Network
On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of $12.46, up 8% year-over-year, beating the consensus of $11.69. The company reported sales of $3.72 ...
Regeneron Pharmaceuticals (NASDAQ: REGN) stock is trading above the $1,000 mark. It's at a high enough threshold that the company could decide to split its stock. That would lower the share price ...
In the latest trading session, Regeneron (REGN) closed at $547.12, marking a +0.49% move from the previous day.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...
Moreover, investors tend to evaluate stock prices relative to earnings. Given this measure, investors might happily pay $704,000 per share when it produces tens of thousands per share in returns ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Regeneron Pharmaceuticals (REGN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes. Regeneron Pharmaceuticals (REGN) Jumps: Stock Rises 6.3% Skip to main ...
Regeneron (REGN) closed the most recent trading day at $735.96, moving -0.01% from the previous trading session.
Ad
related to: regn stock highest price